| |
 |
Simultaneous Optimization of Potency, Selectivity and Physicochemical Properties for Cannabinoid CB2 Ligands
|
| |
|
pp.3345-3366 (22) Authors: Karin Worm, Roland E. Dolle
|
| |
|
|
| |
|
Pathophysiological Insights into Atrial Fibrillation Following Cardiac Surgery: Implications for Current Pharmaceutical Design
|
| |
|
pp.3367-3383 (17) Authors: D. Kaireviciute, A. Aidietis, G. Y.H. Lip
|
| |
|
|
| |
|
Developing Novel Therapeutic Approaches to Frailty
|
| |
|
pp.3384-3395 (12) Author: John E. Morley
|
| |
|
|
| |
|
Role of Chemokines and Their Receptors in Cancer
|
| |
|
pp.3396-3416 (21) Authors: Roeliene C. Kruizinga, Jovanka Bestebroer, Paul Berghuis, Carla J.C. de Haas, Thera P. Links, Elisabeth G.E. de Vries, Annemiek M.E. Walenkamp
|
| |
|
|
| |
|
Vascular Damage in Impaired Glucose Tolerance: An Unappreciated Phenomenon?
|
| |
|
pp.3417-3432 (16) Authors: Shahirose Jessani, Teri Millane, Gregory Y.H. Lip
|
| |
|
|
| |
|
Mast Cells: Target and Source of Neuropeptides
|
| |
|
pp.3433-3445 (13) Authors: F. Tore, N. Tuncel
|
| |
|
|
| |
|
Drug Combinations for Dyslipidemia and Obesity Treatment in Metabolic Syndrome
|
| |
|
pp.3446-3462 (17) Authors: M. Florentin, M. S. Elisaf, D. P. Mikhailidis, E. N. Liberopoulos
|
| |
|
|
